Expert: results of an exit JOINT-STOCK COMPANY "ROSNANO" from "Nanolek" - an example of system effectiveness of state support
Show original
The director of RNC Pharma Rasshchupkin Pawel considers that this transaction will have positive impact on investment climate to Russian Federation...
Analysis
×
Mikhail Nekrasov
Main activity:Official
Andrey Reus
Last position: Chairman of the board of directors (LLC "MBTS "Generium")
Anatoly Chubais
9Last position: Member of Presidium (ARVE)
Rasshchupkin Pawel
JSC Rusnano
8Main activity:Communication and IT
LLC "Nanolek"
Main activity:Science and education
Nanolek Holding Ltd
Organizations
Fund infrastructure and educational programs
Main activity:Science and education
Novartis Int AG
4Main activity:Health care and social services
Kirov region
360Regional centerKirov